Q3 2026 Siemens Healthineers AG Earnings Call Transcript
Key Points
- Siemens Healthineers AG (SMMNY) reported a strong equipment book-to-bill ratio of 1.17% in Q3, indicating robust demand and order intake.
- The company secured two new large value partnerships with prestigious US institutions, Cleveland Clinic and Vanderbilt Health, strengthening its market position.
- Photon counting CT technology is gaining significant traction, accounting for roughly 30% of total CT equipment order volume and driving market share gains.
- The precision therapy segment, particularly advanced therapies, showed strong momentum with the successful launch and ramp-up of the new angiography portfolio.
- The company raised its fiscal 2026 EPS guidance range, driven by tariff refunds, while underlying earnings remain on track despite lower revenue growth.
- Siemens Healthineers AG (SMMNY) lowered its fiscal 2026 revenue growth outlook from 4.5%-5% to 3.5%-4%, primarily due to weaker-than-expected diagnostics performance.
- The diagnostics segment continues to suffer from a significant year-over-year revenue decline, driven by structural market rebasing in China and revenue dilution from legacy platforms.
- Imaging segment growth was softer than anticipated in Q3 due to tough prior-year comparables and temporary revenue shifts into Q4, including site readiness issues.
- The company faces ongoing headwinds from foreign exchange and initial impacts of supply chain inflation, particularly in memory chips, raw materials, and logistics.
- China revenue declined by 10% in Q3, with the diagnostics market down approximately 40% compared to two years ago, and no clear signs of recovery are expected in the near term.
(audio in progress)
This conference call may include forward-looking statements. These statements are based on the company's current expectations and certain assumptions and are therefore (technical difficulty)
Mr. Marc Koebernick, Head of Investor Relations. Please go ahead, sir.
Thank you, operator.
Good morning and welcome to our Q3 earnings call for fiscal 2026. I'd like to thank all of you for joining us today.
This morning at 7 a.m. We published our 2026 results. All related materials for today's results call and release are available on the IR section of the Siemens Healthineers webpage.
Our CEO Bernd Montag and CFO Jochen Schmitz will be taking you through today's presentation as usual.
After the presentations, we will have a Q&A session.
As this has been working out nicely in the past quarters, we kindly ask that all participants limit themselves to one question each with the option of today's call will be made
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
